NCT03597529View on ClinicalTrials.gov

CHOCOlate MeLatonin for AdolescenT MigrainE

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Migraine
Interventions
DRUG

Melatonin

melatonin

Trial Locations (1)

94158

University of California, San Francisco, (UCSF), San Francisco

All Listed Sponsors
lead

Amy Gelfand

OTHER

NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE | Biotech Hunter | Biotech Hunter